−0.325CAD
−27.81 MCAD
53.91 MCAD
32.21 M
About VALEO PHARMA INC
Sector
CEO
Steven Saviuk
Headquarters
Kirkland
Website
Employees (FY)
125
Founded
2003
ISIN
CA91915B1085
FIGI
BBG00NBRD9C0
Valeo Pharma, Inc. engages in the acquisition and in-licensing of branded pharmaceutical and hospital specialty products for sale. Its product portfolio includes respiratory/allergy, specialty products, ophthalmology, neurology, and oncology. The company was founded by Steven Saviuk on March 27, 2003 and is headquartered in Kirkland, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VPH is 0.155 CAD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange VALEO PHARMA INC stocks are traded under the ticker VPH.
VALEO PHARMA INC is going to release the next earnings report on Jul 4, 2024. Keep track of upcoming events with our Earnings Calendar.
VPH stock is 0% volatile and has beta coefficient of 1.10. Check out the list of the most volatile stocks — is VALEO PHARMA INC there?
One year price forecast for VALEO PHARMA INC has a max estimate of 0.600 CAD and a min estimate of 0.400 CAD.
VPH earnings for the last quarter are −0.10 CAD per share, whereas the estimation was −0.05 CAD resulting in a −87.50% surprise. The estimated earnings for the next quarter are −0.08 CAD per share. See more details about VALEO PHARMA INC earnings.
VALEO PHARMA INC revenue for the last quarter amounts to 13.11 M CAD despite the estimated figure of 16.75 M CAD. In the next quarter revenue is expected to reach 14.40 M CAD.
Yes, you can track VALEO PHARMA INC financials in yearly and quarterly reports right on TradingView.
VPH stock hasn't changed in a week, the month change is a 18.42% fall, over the last year VALEO PHARMA INC has showed a 69.00% decrease.
VPH net income for the last quarter is −6.87 M CAD, while the quarter before that showed −9.25 M CAD of net income which accounts for 25.67% change. Track more VALEO PHARMA INC financial stats to get the full picture.
Today VALEO PHARMA INC has the market capitalization of 15.29 M, it has increased by 23.08% over the last week.
No, VPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VALEO PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 125.00 employees. See our rating of the largest employees — is VALEO PHARMA INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VALEO PHARMA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VALEO PHARMA INC stock shows the strong sell signal. See more of VALEO PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on VALEO PHARMA INC future price: according to them, VPH price has a max estimate of 0.60 CAD and a min estimate of 0.40 CAD. Read a more detailed VALEO PHARMA INC forecast: see what analysts think of VALEO PHARMA INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VALEO PHARMA INC EBITDA is −15.57 M CAD, and current EBITDA margin is −27.09%. See more stats in VALEO PHARMA INC financial statements.